MicroPort Endovascular MedTech Ltd (688016) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥46.79 Million ≈ $6.85 Million USD) by net assets (CN¥3.98 Billion ≈ $582.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688016 equity to assets ratio to measure how much of total assets are equity-financed.
MicroPort Endovascular MedTech Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how MicroPort Endovascular MedTech Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is MicroPort Endovascular MedTech Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
MicroPort Endovascular MedTech Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MicroPort Endovascular MedTech Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Peker Gayrimenkul Yatirim Ortakligi AS
IS:PEKGY
|
0.126x |
|
Nuvoton Technology Corp
TW:4919
|
-0.052x |
|
Sanquan Food Co Ltd
SHE:002216
|
0.057x |
|
PLUXEE NV
PA:PLX
|
0.434x |
|
Devyani International Limited
NSE:DEVYANI
|
0.095x |
|
Killam Apartment Real Estate Investment Trust
TO:KMP-UN
|
0.010x |
|
Fujian Kuncai Material Tech
SHG:603826
|
0.061x |
|
Mister Car Wash, Inc. Common Stock
NYSE:MCW
|
0.083x |
Annual Cash Flow Conversion Efficiency for MicroPort Endovascular MedTech Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of MicroPort Endovascular MedTech Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is MicroPort Endovascular MedTech Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.62 Billion ≈ $1.26 Billion |
CN¥573.06 Million ≈ $83.86 Million |
0.066x | -32.01% |
| 2024-12-31 | CN¥3.82 Billion ≈ $559.35 Million |
CN¥373.60 Million ≈ $54.67 Million |
0.098x | -33.89% |
| 2023-12-31 | CN¥3.86 Billion ≈ $565.36 Million |
CN¥571.22 Million ≈ $83.59 Million |
0.148x | -22.81% |
| 2022-12-31 | CN¥1.74 Billion ≈ $255.00 Million |
CN¥333.76 Million ≈ $48.84 Million |
0.192x | -2.91% |
| 2021-12-31 | CN¥1.52 Billion ≈ $222.73 Million |
CN¥300.25 Million ≈ $43.94 Million |
0.197x | +11.95% |
| 2020-12-31 | CN¥1.23 Billion ≈ $180.57 Million |
CN¥217.44 Million ≈ $31.82 Million |
0.176x | +31.17% |
| 2019-12-31 | CN¥1.07 Billion ≈ $155.98 Million |
CN¥143.20 Million ≈ $20.96 Million |
0.134x | -72.82% |
| 2018-12-31 | CN¥216.16 Million ≈ $31.63 Million |
CN¥106.85 Million ≈ $15.64 Million |
0.494x | +34.01% |
| 2017-12-31 | CN¥188.02 Million ≈ $27.51 Million |
CN¥69.36 Million ≈ $10.15 Million |
0.369x | +51.03% |
| 2016-12-31 | CN¥123.38 Million ≈ $18.05 Million |
CN¥30.13 Million ≈ $4.41 Million |
0.244x | -- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more